Poulton Stuart
Transaction: 07/28/2026
SELL
Change
-189
Price
$7.10
Filing
07/30/2026
Type
SELL
Karyopharm Therapeutics Inc.
KPTI • Biotechnology
$0.37
▲ +0.01 (+3.18%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$10.71M
Growth
44.6%
Cash Flow
0/5
Trend
Negative
Evidence
Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:31 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.37
Change3.18%
Shares Out28.94M
Market Cap$10.71M
Enterprise Value$-28.46M
52W Range1.80 - 10.99
Beta0.95
P/E-0.05
P/S0.07
P/B-0.03
P/FCF-0.16
EV/Sales-0.19
Price$0.37
Change3.18%
Shares Out28.94M
Market Cap$10.71M
Enterprise Value$-28.46M
52W Range1.80 - 10.99
Beta0.95
P/E-0.05
P/S0.07
P/B-0.03
P/FCF-0.16
EV/Sales-0.19
EV/EBITDA0.20
EV/FCF0.44
FCF Yield-610.32%
Dividend Yield0.00%
Gross Margin95.93%
Oper. Margin-62.10%
Profit Margin-134.21%
Debt/Eq-0.80
Current Ratio1.12
Quick Ratio1.08
Revenue 5Y44.57%
Target$9.50
Target Upside2467.57%
Target Median$9.50
Target Range3.00 - 16.00
Volume1.67M
Avg Volume923.12K
EPS Surprise0.21
Investment DNA
How strong this company looks for long-term investors
39
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
49/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 20 analyst votes · 2026-10-20
78/100
Bullish
Bullish
13
Hold
5
Bearish
2
Price Target
2026-08-14
Low
$3.00
Mean
$13.20
Median
$16.00
High
$28.00
Insider Transactions
Recent executive and insider activity
Greene Barry E
Transaction: 05/21/2026
BUY
Change
+15,508
Price
Not reported
Filing
05/26/2026
Type
BUY
BOHLIN GAREN G
Transaction: 05/21/2026
BUY
Change
+15,508
Price
Not reported
Filing
05/26/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Poulton Stuart | SELL | -189 | $7.10 | 07/28/2026 | 07/30/2026 |
| Greene Barry E | BUY | +15,508 | Not reported | 05/21/2026 | 05/26/2026 |
| BOHLIN GAREN G | BUY | +15,508 | Not reported | 05/21/2026 | 05/26/2026 |
| Su Zhen | BUY | +15,508 | Not reported | 05/21/2026 | 05/26/2026 |
| Schor Chen | BUY | +15,508 | Not reported | 05/21/2026 | 05/26/2026 |
| PAKIANATHAN DEEPIKA | BUY | +15,508 | Not reported | 05/21/2026 | 05/26/2026 |
| Oliger Christy J. | BUY | +15,508 | Not reported | 05/21/2026 | 05/26/2026 |
| Mano Michael | SELL | -266 | $9.50 | 05/14/2026 | 05/15/2026 |
| Paulson Richard A. | SELL | -2,203 | $9.50 | 05/14/2026 | 05/15/2026 |
| Abate Kristin | SELL | -53 | $9.50 | 05/14/2026 | 05/15/2026 |
| Cheng Sohanya Roshan | SELL | -324 | $9.50 | 05/14/2026 | 05/15/2026 |
| Rangwala Reshma | SELL | -408 | $9.50 | 05/14/2026 | 05/15/2026 |
| Poulton Stuart | SELL | -403 | $9.50 | 05/14/2026 | 05/15/2026 |
| Mano Michael | BUY | +700 | Not reported | 05/13/2026 | 05/15/2026 |
| Paulson Richard A. | BUY | +4,920 | Not reported | 05/13/2026 | 05/15/2026 |
| Abate Kristin | BUY | +121 | Not reported | 05/13/2026 | 05/15/2026 |
| Cheng Sohanya Roshan | BUY | +947 | Not reported | 05/13/2026 | 05/15/2026 |
| Rangwala Reshma | BUY | +947 | Not reported | 05/13/2026 | 05/15/2026 |
| Poulton Stuart | BUY | +896 | Not reported | 05/13/2026 | 05/15/2026 |
| Rangwala Reshma | SELL | -449 | $8.94 | 04/21/2026 | 04/22/2026 |